STING1 and glioblastoma: In this study, we aimed to compare the effects of STING agonist 2′3′-c-di-AM(PS)2 (Rp,Rp) on PTEN-harbouring and PTEN-deficient glioblastoma cell lines in terms of response to temozolomide and cGAS/STING pathway.